These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

454 related items for PubMed ID: 27916865

  • 1. Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome.
    Scott D, Joham A, Teede H, Gibson-Helm M, Harrison C, Cassar S, Hutchison S, Ebeling PR, Stepto N, de Courten B.
    Nutrients; 2016 Nov 30; 8(12):. PubMed ID: 27916865
    [Abstract] [Full Text] [Related]

  • 2. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
    Scott D, Harrison CL, Hutchison S, de Courten B, Stepto NK.
    PLoS One; 2017 Nov 30; 12(8):e0182412. PubMed ID: 28771628
    [Abstract] [Full Text] [Related]

  • 3. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA, Goss AM, Azziz R, Raju DA, Gower BA.
    Hum Reprod; 2017 Jan 30; 32(1):185-192. PubMed ID: 27827322
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
    Joham AE, Teede HJ, Cassar S, Stepto NK, Strauss BJ, Harrison CL, Boyle J, de Courten B.
    Mol Nutr Food Res; 2016 Jan 30; 60(1):110-8. PubMed ID: 26255991
    [Abstract] [Full Text] [Related]

  • 5. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
    Naderpoor N, Shorakae S, Abell SK, Mousa A, Joham AE, Moran LJ, Stepto NK, Spritzer PM, Teede HJ, de Courten B.
    J Steroid Biochem Mol Biol; 2018 Mar 30; 177():209-215. PubMed ID: 28734987
    [Abstract] [Full Text] [Related]

  • 6. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK, Cassar S, Joham AE, Hutchison SK, Harrison CL, Goldstein RF, Teede HJ.
    Hum Reprod; 2013 Mar 30; 28(3):777-84. PubMed ID: 23315061
    [Abstract] [Full Text] [Related]

  • 7. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.
    J Clin Endocrinol Metab; 2011 Jan 30; 96(1):E48-56. PubMed ID: 20926534
    [Abstract] [Full Text] [Related]

  • 8. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial.
    Seyyed Abootorabi M, Ayremlou P, Behroozi-Lak T, Nourisaeidlou S.
    Gynecol Endocrinol; 2018 Jun 30; 34(6):489-494. PubMed ID: 29271278
    [Abstract] [Full Text] [Related]

  • 9. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
    Spranger J, Möhlig M, Wegewitz U, Ristow M, Pfeiffer AF, Schill T, Schlösser HW, Brabant G, Schöfl C.
    Clin Endocrinol (Oxf); 2004 Dec 30; 61(6):738-46. PubMed ID: 15579189
    [Abstract] [Full Text] [Related]

  • 10. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
    Glintborg D, Petersen MH, Ravn P, Hermann AP, Andersen M.
    Acta Obstet Gynecol Scand; 2016 Nov 30; 95(11):1235-1243. PubMed ID: 27529295
    [Abstract] [Full Text] [Related]

  • 11. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.
    Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M.
    J Clin Endocrinol Metab; 2003 Aug 30; 88(8):3626-31. PubMed ID: 12915646
    [Abstract] [Full Text] [Related]

  • 12. The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome.
    Harrison CL, Stepto NK, Hutchison SK, Teede HJ.
    Clin Endocrinol (Oxf); 2012 Mar 30; 76(3):351-7. PubMed ID: 21711376
    [Abstract] [Full Text] [Related]

  • 13. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S, Teede HJ, Moran LJ, Joham AE, Harrison CL, Strauss BJ, Stepto NK.
    Clin Endocrinol (Oxf); 2014 Dec 30; 81(6):899-906. PubMed ID: 25040369
    [Abstract] [Full Text] [Related]

  • 14. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M, Weickert MO, Ghadamgadai E, Machlitt A, Pfüller B, Arafat AM, Pfeiffer AF, Schöfl C.
    Eur J Endocrinol; 2007 Aug 30; 157(2):195-200. PubMed ID: 17656598
    [Abstract] [Full Text] [Related]

  • 15. Pigment epithelium-derived factor, insulin sensitivity, and adiposity in polycystic ovary syndrome: impact of exercise training.
    Joham AE, Teede HJ, Hutchison SK, Stepto NK, Harrison CL, Strauss BJ, Paul E, Watt MJ.
    Obesity (Silver Spring); 2012 Dec 30; 20(12):2390-6. PubMed ID: 22641183
    [Abstract] [Full Text] [Related]

  • 16. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.
    Hum Reprod; 2014 Sep 30; 29(9):2041-9. PubMed ID: 25035436
    [Abstract] [Full Text] [Related]

  • 17. Body fat composition and distribution in women with polycystic ovary syndrome.
    Cosar E, Uçok K, Akgün L, Köken G, Sahin FK, Arioz DT, Baş O.
    Gynecol Endocrinol; 2008 Aug 30; 24(8):428-32. PubMed ID: 18850379
    [Abstract] [Full Text] [Related]

  • 18. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
    Tan BK, Heutling D, Chen J, Farhatullah S, Adya R, Keay SD, Kennedy CR, Lehnert H, Randeva HS.
    Diabetes; 2008 Jun 30; 57(6):1501-7. PubMed ID: 18375437
    [Abstract] [Full Text] [Related]

  • 19. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
    McBreairty LE, Chilibeck PD, Gordon JJ, Chizen DR, Zello GA.
    BMC Endocr Disord; 2019 Jul 01; 19(1):70. PubMed ID: 31262307
    [Abstract] [Full Text] [Related]

  • 20. Impact of hypovitaminosis D on clinical, hormonal and insulin sensitivity parameters in normal body mass index polycystic ovary syndrome women.
    Ganie MA, Marwaha RK, Nisar S, Farooqi KJ, Jan RA, Wani SA, Gojwari T, Shah ZA.
    J Obstet Gynaecol; 2016 May 01; 36(4):508-12. PubMed ID: 26772667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.